Nathalie Baudson

Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells

Wenle Xia, Catherine Gérard, Lei-Hua Liu et al. · Oncogene · 2005 · 262 citations

Breast Oncology, Medicine, Receptor Tyrosine Kinase +11

Loss of Tumorigenicity and Increased Immunogenicity Induced by Interleukin-10 Gene Transfer in B16 Melanoma Cells

Catherine Gérard, Catherine Bruyns, Anne Delvaux et al. · Human Gene Therapy · 1996 · 84 citations

Therapeutic potential of protein and adjuvant vaccinations on tumour growth

Catherine Gérard, Nathalie Baudson, Kristy A Kraemer et al. · Vaccine · 2001 · 67 citations

Vaccinology, Vaccination, Adjuvant Vaccinations +10

Curative Potential of Herpes Simplex Virus Thymidine Kinase Gene Transfer in Rats with 9L Gliosarcoma

Vincent Cool, Benoît Pirotte, Catherine Gérard et al. · Human Gene Therapy · 1996 · 33 citations

Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses

Catherine Gérard, Nathalie Baudson, T. Ory et al. · PLoS ONE · 2014 · 27 citations · Full text